Research

The specialists of Mid Atlantic Retina continue to be in the forefront with their research efforts and in the development of major innovations in retina care. Mid Atlantic Retina participates in several clinical trials investigating new forms of treatment for macular degeneration, diabetic retinopathy, and a variety of other retinal conditions.

Age-related Macular Degeneration (AMD) Studies

• AREDSII  Sponsored by NEI
  The Age-Related Eye Disease Study 2
• CABERNET Sponsored by Neo Vista
  A Study of Strontium90 Beta Radiation With Lucentis to Treat Age-Related Macular Degeneration
• CATT Sponsored by NEI
  Comparison of Age-Related Macular Degeneration Treatments Trials: Lucentis-Avastin Trial
• HORIZON Sponsored by Genentech
  An Extension Study to Evaluate the Safety and Tolerability of Ranibizumab in Subjects With Choroidal Neovascularization Secondary to AMD or Macular Edema Secondary to RVO
• RADICAL Sponsored by QLT, Inc.
  Reduced Fluence Visudyne-Anti-VEGF-Dexamethasone In Combination for AMD Lesions
• VIEW Sponsored by Regeneron
  Double-Masked Study of Efficacy and Safety of IVT VEGF Trap-Eye in Subjects With Wet AMD 

Uveitis Study

• Allergan Study Sponsored by Allergan
  A Study of the Safety and Efficacy of a New Treatment for Non-Infectious Intermediate Uveitis 

Diabetic Macular Edema Study

• Alimera Sponsored by Alimera Sciences
  Fluocinolone Acetonide Implant Compared to Sham Injection in Patients With Diabetic Macular Edema 

Diabetic Retinopathy Study

• ACCORD Sponsored by NHLBI and NEI
  Evaluating How the Treatments in the Action to Control Cardiovascular Risk in Diabetes Study Affect Diabetic Retinopathy
• RISE Sponsored by Genentech
  A Study of Ranibizumab Injection in Subjects With Clinically Significant Macular Edema With Center Involvement Secondary to Diabetes Mellitus (RISE) 

Central Retinal Vein Occlusion Study

• CRUISE Sponsored by Genentech
  A Study of the Efficacy and Safety of Ranibizumab Injection in Patients With Macular Edema Secondary to Central Retinal Vein Occlusion 

Branch Retina Vein Occlusion Study

• BRAVO Sponsored by Genentech
  A Study of the Efficacy and Safety of Ranibizumab Injection in Patients With Macular Edema Secondary to Branch Retinal Vein Occlusion

For additional information, contact our research department directly at
215-928-3092